Related Experiment Video
Updated: Mar 23, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Influences on Technology Use and Efficacy in Type 1 Diabetes
1Raigmore Hospital, Inverness, Scotland, UK University of Aberdeen, Scotland, UK victoria.franklin@nhs.net.
Journal of Diabetes Science and Technology
|March 30, 2016
Summary
Technological advancements in diabetes self-care, including continuous glucose monitoring and insulin pumps, improve outcomes for motivated individuals. However, equitable access and support are crucial to prevent widening health disparities in type 1 diabetes management.
Area of Science:
- Endocrinology and Metabolic Diseases
- Medical Technology and Devices
- Psychology and Behavioral Medicine
Background:
- Suboptimal glycemic control in type 1 diabetes (T1D) elevates complication risks.
- Advanced technologies like continuous glucose monitoring (CGM) and insulin pump therapy (IPT) are key to improving T1D self-management.
- These technologies represent progress towards an artificial pancreas and closed-loop systems.
Purpose of the Study:
- To review psychosocial factors influencing the provision and clinical outcomes of diabetes self-management technologies.
- To examine the impact of these technologies on patients' psychological well-being.
- To identify strategies for optimizing technology adoption and benefits across diverse patient populations.
Main Methods:
- Literature review synthesizing research on psychosocial influences and technology impact in T1D self-care.
- Analysis of factors affecting technology provision, patient motivation, and clinical outcomes.
- Examination of psychological outcomes, treatment satisfaction, and discontinuation rates.
Main Results:
- Optimal use of diabetes technologies is linked to self-care behaviors, demographics, and psychological profiles.
- Psychosocial factors significantly influence the provision and uptake of technologies like IPT.
- Despite increased treatment complexity, adverse psychological effects are not evident, with high satisfaction and low discontinuation rates.
Conclusions:
- Diabetes technology offers significant benefits but requires appropriate education, ongoing support, and psychological assistance for successful implementation.
- Addressing psychosocial factors is essential for maximizing the benefits of diabetes technologies.
- Strategies are needed to ensure equitable access and prevent technology from exacerbating health inequalities, particularly for patients with T1D who may struggle with self-management.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
01:16Insulin: Dosing Regimen and Adverse Effects
1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
01:36Carbohydrate Metabolism
14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
912
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
912